-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report) shares were down 8% on Tuesday . The company traded as low as $7.26 and last traded at $7.49. Approximately 1,334,198 shares traded hands during mid-day trading, a decline of 60% from the average daily volume of 3,376,665 shares. The stock had previously closed at $8.14.
Mind Medicine (MindMed) Price Performance
The stock’s 50 day simple moving average is $6.71 and its two-hundred day simple moving average is $7.08.
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
See Also
- Five stocks we like better than Mind Medicine (MindMed)
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- What is the FTSE 100 index?
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- How to Calculate Options Profits
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
